• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Wednesday

    8/2/23 1:55:33 PM ET
    $RDHL
    $RDWR
    $SILV
    $SNES
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Real Estate
    Real Estate
    Get the next $RDHL alert in real time by email

     

    During Wednesday's trading, 103 companies set new 52-week lows.

    Interesting Facts About Today's 52-Week Lows:

    • Estee Lauder Cos (NYSE:EL) was the biggest company in terms of market cap to set a new 52-week low.
    • Esports Entertainment (NASDAQ:GMBL) was the smallest company in terms of market cap to set a new 52-week low.
    • ExlService Holdings (NASDAQ:EXLS)'s stock moved significantly downwards, trading down 80.66% to reach a new 52-week low.
    • IDT (NYSE:IDT) saw the biggest bounce back on, as shares traded up 0.04% to rebound after it hit its new 52-week low.

    The following stocks created new 52-week lows on Wednesday:

    • Estee Lauder Cos (NYSE:EL) stock drifted down 1.97% on Wednesday morning to hit a new 52-week low of $170.90.
    • Moderna (NASDAQ:MRNA) shares hit a yearly low of $110.84. The stock was down 2.27% on the session.
    • TELUS (NYSE:TU) shares set a new yearly low of $17.32 this morning. The stock was down 2.17% on the session.
    • Enphase Energy (NASDAQ:ENPH) stock drifted down 5.9% on Wednesday morning to hit a new 52-week low of $140.28.
    • ZoomInfo Technologies (NASDAQ:ZI) shares reached a new 52-week low of $18.31 on Wednesday morning, moving down 0.59%.
    • Agree Realty (NYSE:ADC) stock dropped to a yearly low on Wednesday of $62.79. Shares traded down 2.8%.
    • ExlService Holdings (NASDAQ:EXLS) stock dropped to a yearly low on Wednesday of $27.22. Shares traded down 80.66%.
    • PNM Resources (NYSE:PNM) stock set a new 52-week low of $44.30 on Wednesday, moving down 0.39%.
    • Insperity (NYSE:NSP) shares hit a yearly low of $94.00. The stock was down 3.56% on the session.
    • Spire (NYSE:SR) stock hit $59.49 on Wednesday morning, setting a new 52-week low for a change of down 3.4%.
    • NovoCure (NASDAQ:NVCR) stock drifted down 6.98% on Wednesday morning to hit a new 52-week low of $30.21.
    • Cytokinetics (NASDAQ:CYTK) stock achieved a new 52-week low on Wednesday morning, hitting $31.46 and moving down 1.54%.
    • Clearway Energy (NYSE:CWEN) shares set a new 52-week low of $25.17. The stock traded down 2.48%.
    • National Storage (NYSE:NSA) shares fell to $32.80 on Wednesday, setting a new 52-week low with a shift of down 0.8%.
    • Apellis Pharmaceuticals (NASDAQ:APLS) stock set a new 52-week low of $22.73 on Wednesday, moving down 4.91%.
    • Sensient Technologies (NYSE:SXT) stock broke to a new 52-week low of $62.64 on Wednesday. Shares of the company traded down 1.48%.
    • TELUS Intl (NYSE:TIXT) shares fell to $8.74 on Wednesday, setting a new 52-week low with a shift of down 3.41%.
    • Driven Brands Hldgs (NASDAQ:DRVN) stock hit a new 52-week low of $13.15. The stock was down 48.68% on the session.
    • Beam Therapeutics (NASDAQ:BEAM) shares set a new yearly low of $27.46 this morning. The stock was down 1.86% on the session.
    • Perficient (NASDAQ:PRFT) stock dropped to a yearly low on Wednesday of $58.94. Shares traded down 2.74%.
    • Impinj (NASDAQ:PI) stock drifted down 4.11% on Wednesday morning to hit a new 52-week low of $62.44.
    • Pacira BioSciences (NASDAQ:PCRX) shares fell to $34.08 on Wednesday, setting a new 52-week low with a shift of up 0.64%.
    • SunPower (NASDAQ:SPWR) stock broke to a new 52-week low of $8.94 on Wednesday. Shares of the company traded down 8.99%.
    • Maravai LifeSciences (NASDAQ:MRVI) shares fell to $10.78 on Wednesday, setting a new 52-week low with a shift of up 4.94%.
    • Duckhorn Portfolio (NYSE:NAPA) shares were down 0.12% for the day, having made a 52-week low of $12.35.
    • Nu Skin Enterprises (NYSE:NUS) shares hit a yearly low of $27.50. The stock was down 6.29% on the session.
    • BioCryst Pharma (NASDAQ:BCRX) stock hit a yearly low of $6.78. The stock was down 0.22% for the day.
    • Horace Mann Educators (NYSE:HMN) stock broke to a new 52-week low of $28.15 on Wednesday. Shares of the company traded down 5.68%.
    • Monro (NASDAQ:MNRO) stock broke to a new 52-week low of $34.94 on Wednesday. Shares of the company traded down 2.34%.
    • Hain Celestial Group (NASDAQ:HAIN) stock broke to a new 52-week low of $11.50 on Wednesday. Shares of the company traded down 2.59%.
    • Infinera (NASDAQ:INFN) stock hit a yearly low of $4.22. The stock was down 2.19% for the day.
    • Suburban Propane Partners (NYSE:SPH) stock broke to a new 52-week low of $14.42 on Wednesday. Shares of the company traded down 0.96%.
    • IntL Money Express (NASDAQ:IMXI) stock hit a yearly low of $19.31. The stock was down 16.84% for the day.
    • Radware (NASDAQ:RDWR) shares set a new yearly low of $14.96 this morning. The stock was down 15.39% on the session.
    • Nevro (NYSE:NVRO) shares set a new yearly low of $18.55 this morning. The stock was down 23.88% on the session.
    • SilverCrest Metals (AMEX:SILV) stock dropped to a yearly low on Wednesday of $4.16. Shares traded down 6.15%.
    • IDT (NYSE:IDT) shares fell to $22.76 on Wednesday, setting a new 52-week low with a shift of up 0.04%.
    • Anterix (NASDAQ:ATEX) stock hit a yearly low of $27.20. The stock was up 2.05% for the day.
    • ModivCare (NASDAQ:MODV) shares set a new 52-week low of $35.68. The stock traded down 2.0%.
    • Beneficient (NASDAQ:BENF) shares set a new yearly low of $1.80 this morning. The stock was down 6.5% on the session.
    • Artesian Resources (NASDAQ:ARTNA) shares fell to $45.01 on Wednesday, setting a new 52-week low with a shift of up 0.53%.
    • Fate Therapeutics (NASDAQ:FATE) stock achieved a new 52-week low on Wednesday morning, hitting $3.73 and moving down 4.79%.
    • 2seventy bio (NASDAQ:TSVT) shares moved down 3.03% on Wednesday to hit a new 52-week low of $6.63, drifting down 3.03%.
    • PSQ Holdings (NYSE:PSQH) shares hit a yearly low of $11.57. The stock was down 6.55% on the session.
    • Cambium Networks (NASDAQ:CMBM) shares were down 37.64% for the day, having made a 52-week low of $8.84.
    • BRC (NYSE:BRCC) stock hit a new 52-week low of $4.21. The stock was down 4.39% on the session.
    • TPI Composites (NASDAQ:TPIC) shares moved down 0.78% on Wednesday to hit a new 52-week low of $5.53, drifting down 0.78%.
    • Gold Royalty (AMEX:GROY) stock hit $1.65 on Wednesday morning, setting a new 52-week low for a change of down 4.6%.
    • Nuveen Virginia Quality (NYSE:NPV) stock drifted down 0.92% on Wednesday morning to hit a new 52-week low of $10.60.
    • Orchestra BioMed Hldgs (NASDAQ:OBIO) shares set a new 52-week low of $5.19. The stock traded down 4.0%.
    • Prelude Therapeutics (NASDAQ:PRLD) shares were down 2.71% for the day, having made a 52-week low of $3.56.
    • NGM Biopharmaceuticals (NASDAQ:NGM) shares moved down 1.98% on Wednesday to hit a new 52-week low of $2.16, drifting down 1.98%.
    • Inogen (NASDAQ:INGN) shares set a new 52-week low of $7.54. The stock traded down 3.55%.
    • Akoustis Technologies (NASDAQ:AKTS) shares moved down 2.56% on Wednesday to hit a new 52-week low of $2.26, drifting down 2.56%.
    • Complete Solaria (NASDAQ:CSLR) shares hit a yearly low of $3.14. The stock was down 5.0% on the session.
    • Electrovaya (NASDAQ:ELVA) stock set a new 52-week low of $4.05 on Wednesday, moving up 4.1%.
    • Zevia (NYSE:ZVIA) stock dropped to a yearly low on Wednesday of $2.65. Shares traded down 2.36%.
    • Platinum Gr Metals (AMEX:PLG) shares set a new yearly low of $1.27 this morning. The stock was down 4.51% on the session.
    • Loop Media (AMEX:LPTV) stock hit a yearly low of $2.13. The stock was down 3.59% for the day.
    • G1 Therapeutics (NASDAQ:GTHX) shares set a new 52-week low of $2.11. The stock traded up 0.68%.
    • PaySign (NASDAQ:PAYS) shares fell to $1.82 on Wednesday, setting a new 52-week low with a shift of down 3.19%.
    • Byrna Technologies (NASDAQ:BYRN) shares were down 3.14% for the day, having made a 52-week low of $3.30.
    • TD Hldgs (NASDAQ:GLG) shares hit a yearly low of $0.47. The stock was down 2.69% on the session.
    • Ohmyhome (NASDAQ:OMH) shares were down 0.94% for the day, having made a 52-week low of $2.72.
    • Zapp Electric Vehicles (NASDAQ:ZAPP) shares made a new 52-week low of $1.40 on Wednesday. The stock was down 4.7% for the day.
    • AquaBounty Techs (NASDAQ:AQB) stock hit $0.31 on Wednesday morning, setting a new 52-week low for a change of down 9.97%.
    • Phoenix New Media (NYSE:FENG) stock achieved a new 52-week low on Wednesday morning, hitting $1.61 and moving up 1.2%.
    • Cosmos Health (NASDAQ:COSM) stock achieved a new 52-week low on Wednesday morning, hitting $1.35 and moving down 4.08%.
    • Polished.com (AMEX:POL) stock hit a new 52-week low of $0.17. The stock was down 13.61% on the session.
    • ShiftPixy (NASDAQ:PIXY) stock hit a new 52-week low of $1.01. The stock was down 7.21% on the session.
    • Treasure Global (NASDAQ:TGL) stock hit a new 52-week low of $0.65. The stock was down 6.3% on the session.
    • Tonix Pharmaceuticals (NASDAQ:TNXP) shares moved down 2.43% on Wednesday to hit a new 52-week low of $0.99, drifting down 2.43%.
    • Biophytis (NASDAQ:BPTS) shares were down 1.16% for the day, having made a 52-week low of $1.67.
    • Taoping (NASDAQ:TAOP) stock drifted down 13.12% on Wednesday morning to hit a new 52-week low of $4.11.
    • Yoshiharu Global (NASDAQ:YOSH) shares were down 4.96% for the day, having made a 52-week low of $0.51.
    • Universe Pharmaceuticals (NASDAQ:UPC) stock hit a new 52-week low of $1.68. The stock was down 8.68% on the session.
    • Redhill Biopharma (NASDAQ:RDHL) stock broke to a new 52-week low of $1.15 on Wednesday. Shares of the company traded down 7.2%.
    • Biolase (NASDAQ:BIOL) stock dropped to a yearly low on Wednesday of $5.11. Shares traded down 8.89%.
    • Synaptogenix (NASDAQ:SNPX) shares made a new 52-week low of $0.67 on Wednesday. The stock was down 8.51% for the day.
    • Phio Pharma (NASDAQ:PHIO) shares fell to $2.53 on Wednesday, setting a new 52-week low with a shift of down 2.99%.
    • NanoVibronix (NASDAQ:NAOV) shares moved down 5.37% on Wednesday to hit a new 52-week low of $2.82, drifting down 5.37%.
    • Digital Brands Group (NASDAQ:DBGI) shares set a new yearly low of $0.55 this morning. The stock was up 1.26% on the session.
    • Aptevo Therapeutics (NASDAQ:APVO) stock hit a yearly low of $0.58. The stock was down 39.89% for the day.
    • Intelligent Bio Solutions (NASDAQ:INBS) shares set a new 52-week low of $1.71. The stock traded down 1.21%.
    • Adamis Pharmaceuticals (NASDAQ:ADMP) shares set a new 52-week low of $1.28. The stock traded down 63.91%.
    • Ault Alliance (AMEX:AULT) shares set a new yearly low of $2.61 this morning. The stock was down 8.36% on the session.
    • Oblong (NASDAQ:OBLG) stock achieved a new 52-week low on Wednesday morning, hitting $1.22 and moving down 1.6%.
    • SenesTech (NASDAQ:SNES) shares were down 1.1% for the day, having made a 52-week low of $0.88.
    • NeuBase Therapeutics (NASDAQ:NBSE) stock achieved a new 52-week low on Wednesday morning, hitting $1.20 and moving down 1.55%.
    • Akanda (NASDAQ:AKAN) shares fell to $0.58 on Wednesday, setting a new 52-week low with a shift of down 3.78%.
    • Allarity Therapeutics (NASDAQ:ALLR) shares reached a new 52-week low of $2.24 on Wednesday morning, moving down 8.03%.
    • Esports Entertainment (NASDAQ:GMBL) stock dropped to a yearly low on Wednesday of $0.33. Shares traded down 13.88%.

    Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. Click here to learn more.

    Get the next $RDHL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $RDHL
    $RDWR
    $SILV
    $SNES

    CompanyDatePrice TargetRatingAnalyst
    Enphase Energy Inc.
    $ENPH
    12/29/2025$52.00 → $62.00Outperform
    Northland Capital
    Electrovaya Inc.
    $ELVA
    12/18/2025$14.00Outperform
    Oppenheimer
    Enphase Energy Inc.
    $ENPH
    12/18/2025$29.00Sell → Neutral
    Goldman
    Cytokinetics Incorporated
    $CYTK
    12/18/2025$95.00Neutral → Buy
    Goldman
    Clearway Energy Inc.
    $CWEN
    12/17/2025$38.00Neutral → Sector Outperform
    CIBC
    Spire Inc.
    $SR
    12/16/2025$92.00Equal-Weight → Overweight
    Morgan Stanley
    Moderna Inc.
    $MRNA
    12/12/2025$30.00Hold
    Jefferies
    Telus Corporation
    $TU
    12/11/2025Outperform → Market Perform
    BMO Capital Markets
    More analyst ratings

    $RDHL
    $RDWR
    $SILV
    $SNES
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Taylor Andrew Lawrence covered exercise/tax liability with 3,452 shares, decreasing direct ownership by 0.76% to 451,493 units (SEC Form 4)

    4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)

    1/2/26 6:55:28 PM ET
    $OBIO
    Medicinal Chemicals and Botanical Products
    Health Care

    Principal Accounting Officer Aiello Joshua covered exercise/tax liability with 241 shares, decreasing direct ownership by 1% to 18,885 units (SEC Form 4)

    4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)

    1/2/26 6:54:52 PM ET
    $OBIO
    Medicinal Chemicals and Botanical Products
    Health Care

    Officer Sherman Darren covered exercise/tax liability with 5,588 shares, decreasing direct ownership by 0.66% to 840,569 units (SEC Form 4)

    4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)

    1/2/26 6:53:59 PM ET
    $OBIO
    Medicinal Chemicals and Botanical Products
    Health Care

    $RDHL
    $RDWR
    $SILV
    $SNES
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chairman, Pres. & CEO Bitterman Robert J bought $5,150 worth of shares (5,000 units at $1.03), increasing direct ownership by 2% to 291,421 units (SEC Form 4)

    4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)

    1/2/26 4:05:06 PM ET
    $PHIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Rakolta John Jr gifted 11,549 shares and bought $1,082,700 worth of shares (15,000 units at $72.18), increasing direct ownership by 0.62% to 562,606 units (SEC Form 4)

    4 - AGREE REALTY CORP (0000917251) (Issuer)

    12/29/25 4:30:08 PM ET
    $ADC
    Real Estate Investment Trusts
    Real Estate

    Chairman, Pres. & CEO Bitterman Robert J bought $5,100 worth of shares (5,000 units at $1.02), increasing direct ownership by 2% to 286,421 units (SEC Form 4)

    4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)

    12/29/25 8:10:21 AM ET
    $PHIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $RDHL
    $RDWR
    $SILV
    $SNES
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    October 18, 2024 - FDA Roundup: October 18, 2024

    For Immediate Release: October 18, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  This week, FDA continues ongoing efforts to increase access and supply of IV and peritoneal dialysis (PD) fluids following Hurricane Helene-related damage to Baxter International Inc.’s facility in Marion, North Carolina. Specifically, FDA acted quickly to c

    10/18/24 4:16:25 PM ET
    $NVCR
    $BAX
    Medical/Dental Instruments
    Health Care

    FDA Approval for ZIMHI issued to ADAMIS PHARMS CORP

    Submission status for ADAMIS PHARMS CORP's drug ZIMHI (ORIG-1) with active ingredient NALOXONE HYDROCHLORIDE has changed to 'Approval' on 10/15/2021. Application Category: NDA, Application Number: 212854, Application Classification: Type 5 - New Formulation or New Manufacturer

    10/18/21 11:55:40 AM ET
    $ADMP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for SYMJEPI issued to ADAMIS PHARMS CORP

    Submission status for ADAMIS PHARMS CORP's drug SYMJEPI (SUPPL-12) with active ingredient EPINEPHRINE has changed to 'Approval' on 06/29/2021. Application Category: NDA, Application Number: 207534, Application Classification: Labeling

    6/30/21 5:11:48 AM ET
    $ADMP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $RDHL
    $RDWR
    $SILV
    $SNES
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Northland Capital reiterated coverage on Enphase Energy with a new price target

    Northland Capital reiterated coverage of Enphase Energy with a rating of Outperform and set a new price target of $62.00 from $52.00 previously

    12/29/25 10:01:08 AM ET
    $ENPH
    Semiconductors
    Technology

    Oppenheimer initiated coverage on Electrovaya with a new price target

    Oppenheimer initiated coverage of Electrovaya with a rating of Outperform and set a new price target of $14.00

    12/18/25 9:09:07 AM ET
    $ELVA

    Enphase Energy upgraded by Goldman with a new price target

    Goldman upgraded Enphase Energy from Sell to Neutral and set a new price target of $29.00

    12/18/25 8:41:38 AM ET
    $ENPH
    Semiconductors
    Technology

    $RDHL
    $RDWR
    $SILV
    $SNES
    SEC Filings

    View All

    Amendment: SEC Form S-1/A filed by Akoustis Technologies Inc.

    S-1/A - Aktis Oncology, Inc. (0002035832) (Filer)

    1/5/26 6:31:35 AM ET
    $AKTS
    Telecommunications Equipment
    Utilities

    SEC Form EFFECT filed by Beneficient

    EFFECT - Beneficient (0001775734) (Filer)

    1/5/26 12:15:12 AM ET
    $BENF
    Finance: Consumer Services
    Finance

    Intelligent Bio Solutions Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits

    8-K - INTELLIGENT BIO SOLUTIONS INC. (0001725430) (Filer)

    1/2/26 5:10:30 PM ET
    $INBS
    Medical/Dental Instruments
    Health Care

    $RDHL
    $RDWR
    $SILV
    $SNES
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    TELUS leadership, including Board of Directors and CEO, demonstrates confidence in the Company's future with share purchases

    VANCOUVER, BC, Jan. 5, 2026 /CNW/ - TELUS Corporation ("TELUS" or the "Company") today announced that several members of its board of directors and its executive leadership team, including Darren Entwistle, President and CEO of TELUS, through the course of November and December have acquired a total of 357,090 additional TELUS shares in the open market, reflecting their confidence in TELUS' compelling value proposition and long-term growth prospects. Collectively, senior officers of TELUS' executive leadership team and board of directors hold a total of approximately 2.4 milli

    1/5/26 6:45:00 AM ET
    $TU
    Telecommunications Equipment
    Telecommunications

    Intelligent Bio Solutions Announces Closing of $10.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

    NEW YORK, Jan. 02, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. ("INBS" or the "Company") (NASDAQ:INBS), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the closing of its previously announced private placement with two healthcare focused institutional investors priced at-the-market under Nasdaq rules of 2,298,850 shares of common stock (or pre-funded warrants in lieu thereof), Series K-1 warrants to purchase up to an aggregate of 2,298,850 shares of common stock and Series K-2 warrants to purchase up to an aggregate of 2,298,850 shares of common stock, at a combined purchase price of $4.35 per share of common stock (or

    1/2/26 5:00:00 PM ET
    $INBS
    Medical/Dental Instruments
    Health Care

    GoldMining Reports Management Change

    Designated News Release VANCOUVER, BC, Jan. 2, 2026 /PRNewswire/ -– GoldMining Inc. (the "Company" or "GoldMining") (TSX:GOLD) (NYSE:GLDG) announces that Paulo Pereira has resigned from his role as President of the Company to assume the role of Country Manager, Brazil. Alastair Still, Chief Executive Officer of the Company, will assume the additional role of President, effective January 1, 2026. Alastair Still, President and Chief Executive Officer of GoldMining, commented: "Appointing Paulo Pereira as Country Manager, Brazil is a step that allows Paulo to focus attention dire

    1/2/26 7:00:00 AM ET
    $GLDG
    $GROY
    $USGO
    Precious Metals
    Basic Materials

    $RDHL
    $RDWR
    $SILV
    $SNES
    Leadership Updates

    Live Leadership Updates

    View All

    Radware Reports Results of 2025 Annual General Meeting

    TEL AVIV, Israel, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Radware® (NASDAQ:RDWR), a global leader in application security and delivery solutions for multi-cloud environments, today announced the results of its Annual General Meeting of Shareholders held December 22, 2025. The Company presented four proposals for the shareholders to vote on at the meeting, of which one proposal (to approve compensation terms of, including grants of equity-based awards to, non-employee directors and related amendments to the Compensation Policy) was not adopted by the requisite shareholder vote. The three other proposals voted on at the Annual General Meeting were adopted by the requisite shareholder vote. About

    12/23/25 6:01:00 AM ET
    $RDWR
    Real Estate

    Driven Brands Announces Appointment of Timothy Johnson to Board of Directors

    Driven Brands Holdings Inc. (NASDAQ:DRVN) ("Driven Brands" or the "Company") today announced the election of Timothy Johnson as an independent director to its Board of Directors, effective January 1, 2026. Upon his election, Johnson will also serve as a member of the Audit Committee. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251222167611/en/Timothy Johnson "We're excited to expand our Board with the addition of Tim," said Jonathan Fitzpatrick, Non-Executive Chair of the Board. "He brings leadership and financial expertise along with a strong understanding of today's competitive landscape that will provide valuable perspecti

    12/22/25 7:15:00 AM ET
    $DRVN
    Automotive Aftermarket
    Consumer Discretionary

    Radware Announces Major New Customer Win

    MAHWAH, N.J., Dec. 22, 2025 (GLOBE NEWSWIRE) -- Radware® (NASDAQ:RDWR), a global leader in application security and delivery solutions for multi-cloud environments, today announced a significant new multi-year customer win with a leading global SaaS enterprise software company. As part of the agreement, the customer has deployed Radware's DefensePro® DDoS mitigation solution to protect its critical applications and infrastructure. Prior to selecting Radware, the company had been experiencing repeated DDoS attacks ranging from approximately 30 Gbps to more than 600 Gbps and required a solution capable of providing consistently fast and reliable mitigation. In addition to addressing immedi

    12/22/25 6:00:00 AM ET
    $RDWR
    Real Estate

    $RDHL
    $RDWR
    $SILV
    $SNES
    Financials

    Live finance-specific insights

    View All

    TELUS leadership, including Board of Directors and CEO, demonstrates confidence in the Company's future with share purchases

    VANCOUVER, BC, Jan. 5, 2026 /CNW/ - TELUS Corporation ("TELUS" or the "Company") today announced that several members of its board of directors and its executive leadership team, including Darren Entwistle, President and CEO of TELUS, through the course of November and December have acquired a total of 357,090 additional TELUS shares in the open market, reflecting their confidence in TELUS' compelling value proposition and long-term growth prospects. Collectively, senior officers of TELUS' executive leadership team and board of directors hold a total of approximately 2.4 milli

    1/5/26 6:45:00 AM ET
    $TU
    Telecommunications Equipment
    Telecommunications

    Cytokinetics Announces FDA Approval of MYQORZO™ (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy to Improve Functional Capacity and Symptoms

    MYQORZO, a Cardiac Myosin Inhibitor, Directly Addresses Underlying Hypercontractility Associated with Obstructive HCM FDA Approval Based on Results of SEQUOIA-HCM MYQORZO is Company's First FDA-Approved Medicine Company to Host Investor Conference Call Today at 4:30 PM Eastern Time SOUTH SAN FRANCISCO, Calif., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (NASDAQ:CYTK) today announced that the U.S. Food and Drug Administration (FDA) has approved MYQORZO™ (aficamten), 5 mg, 10 mg, 15 mg, 20 mg tablets for the treatment of adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM) to improve functional capacity and symptoms. MYQORZO is an allosteric and rever

    12/19/25 4:00:00 PM ET
    $CYTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    KBW Announces Index Rebalancing for Fourth-Quarter 2025

    NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Keefe, Bruyette & Woods, Inc., a leading specialist investment bank to the financial services and fintech sectors, and a wholly owned subsidiary of Stifel Financial Corp. (NYSE:SF), announces the upcoming index rebalancing for the fourth quarter of 2025. This quarter, there are constituent changes within six of our indexes: KBW Nasdaq Insurance Index (Index Ticker: KIX), KBW Nasdaq Regional Banking Index (Index Ticker: KRX, ETF Ticker: KBWR), KBW Nasdaq Financial Sector Dividend Yield Index (Index Ticker: KDX, ETF Ticker: KBWD), KBW Nasdaq Premium Yield Equity REIT Index (Index Ticker: KYX, ETF Ticker: KBWY), KBW Nasdaq Property and Casualty Ins

    12/12/25 8:30:00 PM ET
    $AAT
    $ACIW
    $AJG
    Real Estate Investment Trusts
    Real Estate
    Computer Software: Prepackaged Software
    Technology

    $RDHL
    $RDWR
    $SILV
    $SNES
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by ModivCare Inc.

    SC 13D/A - ModivCare Inc (0001220754) (Subject)

    12/13/24 9:05:42 PM ET
    $MODV
    Transportation Services
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by ModivCare Inc.

    SC 13D/A - ModivCare Inc (0001220754) (Subject)

    12/13/24 5:07:48 PM ET
    $MODV
    Transportation Services
    Consumer Discretionary

    SEC Form SC 13G filed by PSQ Holdings Inc.

    SC 13G - PSQ Holdings, Inc. (0001847064) (Subject)

    12/12/24 11:50:43 AM ET
    $PSQH
    Advertising
    Consumer Discretionary